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Objectives. We sought o determine whether abnormalities in
small intramyocardial vessels could be detected on routine car- 
diac transplant biopsy specimens and whether these features 
correlate with intimal thickening by intracoronary ultrasound and 
endothelial dysfunction i large epicardial vessels. 
Background. Variability in clinical presentation of allograft 
vasculopathy suggests differential involvement oflarge and small 
vessels. Intracoronary ultrasound and endothelial function stud- 
ies detect large-vessel abnormalities but may not reflect changes 
in small intramyocardial rteries. The latter could be detected in 
routine cardiac biopsy specimens by histologic and immunohisto- 
chemical studies. 
Methods. Thirty-nine cardiac transplant recipients underwent 
intracorona~ ultrasound and acetylcholine studies 5 to 7 days 
after endomyocardial biopsy. Biopsy tissue was evaluated for 
coronary artery endothelial plumping and intimal thickening and 
increased immunostaining for fibronectin, tumor necrosis factor- 
alpha and receptor for hyaluronan-mediated motility. Large- 
vessel disease was assessed by calculating an average intimal 
index from intracoronary ultrasound of the left anterior descend- 
ing coronary artery. Endothelial function was determined by 
quantitative coronary analysis after acetylcholine challenge. 
Results. Coronary arteries were found in the biopsy tissue of 30 
(76%) of the 39 patients who formed the study group. Fourteen of 
30 patients had abnormal histologic findings. Immnnohistochem- 
ical analysis for fibronectin, possible in 20 of 30 patients, was 
positive in 14 (70%) of 20 and correlated with abnormal histologic 
findings (p = 0.01). Immunostaining was positive for tumor 
necrosis factor-alpha nd receptor for hyaluronan-mediated mo- 
tility in 12 (40%) and 13 (43%) of 30 patients, respectively. All
patients had intimal thickening by intracoronary ultrasound, but 
intimal index did not correlate significantly with small-artery 
disease by histoiogic or immunohistochemical analysis. Large- 
vessel endothelial dysfunction in 13 patients (43%) did not 
correlate with either abnormal ultrasound findings or small- 
vessel disease. 
Conclusions. Intramyocardial rteries are readily observed in 
biopsy specimens from cardiac transplant recipients and provide 
useful information about allograft vasculopathy. Lack of correla- 
tion between i tramyocardial nd epicardial vessel disease sug- 
gests discordant progression of allograft vasculopathy. 
(J Am Coil Cardio11995;26:110-9) 
Clinical manifestations of cardiac allograft vasculopathy include 
acute myocardial infarction, progressive heart failure and sudden 
death (1). The association of cardiac events with findings com- 
patible with coronary artery disease by coronary angiography is 
poor because in many cases severe heart failure occurs in the 
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presence of patent vessels (2). More recently, the use of intra- 
coronary ultrasound has improved the early diagnosis of large- 
vessel coronary artery disease (3), but the extent of intramyocar- 
dial small-artery disease remains relatively unexplored. In one 
report in which small-artery changes were observed in an endo- 
myocardial biopsy specimen, the concurrent coronary angio- 
graphic findings were normal, but the patient subsequently died 
of a myocardial infarction (4). It was therefore proposed that 
endomyocardial biopsy could provide useful information on the 
development of allograft vasculopathy (4). However, the histo- 
logic appearance of small intramyocardial arteries, and whether 
vascular changes at this level correlate with large epicardial 
disease, as detected by ultrasound or acetylcholine infusion in a 
cohort of surviving patients over a cross section of time after 
transplantation have not been reported. 
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Routine surveillance cardiac biopsy provides repeated sam- 
piing of myocardial tissue that could be used to assess involve- 
ment and progression of intramyocardial coronary artery 
disease, both by routine histologic findings and specific immu- 
nohistochemistry markers associated with allograft vasculopa- 
thy. We previously (5) demonstrated xperimentally in piglets 
after cardiac transplantation that allograft vasculopathy was 
associated with an immune-inflammatory reaction in the vessel 
wall characterized by the expression of major histocompatibil- 
ity complex II antigens, infiltration of T-cell subsets, induction 
of cytokines (interleukin-l-beta and tumor necrosis factor- 
alpha) and increased accumulation of the extracellular matrix 
component fibronectin (5). We also previously showed (6) in 
ductus arteriosus that increased fibronectin accumulation was 
related to increased migration of smooth muscle cells charac- 
terized by increased expression of the receptor for hyaluronan- 
mediated motility (RHAMM) in the lamellipodia (6,7). 
The purpose of the present study was to assess mall 
intramyocardial rteries in endomyocardial biopsy specimens 
by histologic and immunobistocbemical studies to determine 
whether findings compatible with small-artery disease seen 
experimentally were also evident in patients after cardiac 
transplantation a d to correlate these observations with find- 
ings of large-vessel disease, as assessed by intracoronary ultra- 
sound and acetylcholine infusion in the same cardiac trans- 
plant recipients. We demonstrated that small arteries can 
readily be observed in endomyocardial biopsy specimens and 
that abnormal vascular histologic findings, that is, endothelial 
abnormalities and intimal thickening, were consistently associ- 
ated with the accumulation of fibronectin and frequently with 
the expression of the immune inflammatory, mediator tumor 
necrosis factor-alpha and the marker for RHAMM in smooth 
muscles. However, we also observed that small-artery changes 
did not correlate with the involvement of large coronary 
arteries by intracoronary ultrasound measurements or acetyl- 
choline infusion, suggesting temporally or etiologically differ- 
ent pathophysiologic mechanisms. 
Methods  
Patients. Thirty-nine cardiac transplant recipients (36 men, 
3 women; mean [_+SD] age 52 _+ 8 years, range 26 to 62; mean 
time after-cardiac transplantation 24 _+ 18 months, range 2 to 
60; mean donor age 30 _-2 11 years) underwent intracoronary 
ultrasound before routine coronary angiography at The To- 
ronto Hospital between January and December 1992. These 
patients were selected from our cardiac transplant recipient 
population for stable clinical status, absence of coronary lumen 
obstruction >50% and ease of follow-up. They were enrolled 
in an ongoing study to assess progression of allograft vascu- 
lopathy by intravascular ultrasound and acetylcholine chal- 
lenge. At transplantation, all patients received induction ther- 
apy with antilymphocyte preparations. They were maintained 
with triple immunosuppression (cyclosporine, azathioprine 
and prednisone), and the target plasma level for cyclosporine 
was 200 to 300/zg/dl. All patients unde~'ent endomyocardial 
biopsy 5 to 7 days before intravascular ultrasound as well as 
acetylcholine and angiographic studies, and all were free of 
cellular rejection requiring treatment. Written informed con- 
sent was obtained from all patients, and all studies were carried 
out according to the guidelines of the Human Ethics Review 
Committee of The Toronto Hospital. 
Histopathologic analysis of endomyocardial biopsy speci- 
mens. Vascular changes. Endomyocardial biopsy was per- 
formed using standard techniques, and at least five pieces of 
tissue were obtained in each procedure. Paraffin-embedded 
sections of the specimens were stained with hematoxylin-eosin 
and elastic-trichrome. The sections were retrospectively re- 
viewed by two observers (N.C., J.B.) under a standard light 
microscope using 10×, 20× and 60x objectives. The observers 
were blinded to clinical history, ultrasound measurements and 
acetylcholine study findings. An artery was considered normal 
if the intima comprised a single layer of flat endothelial cells, 
the internal elastic lamina was intact, the media showed no 
fibrosis, and the adventitia was not thickened. When vessels 
with three layers were visualized in the biopsy sections, they 
were qualitatively assessed for the presence of plump (swollen) 
endothelial cells or intimal thickening of the vessel wall as 
indicators of allograft vasculopathy (8). Arteries (excluding 
capillaries) in any biopsy sample of myocardium were evalu- 
ated for tangential cuts to avoid inaccurate assessment of 
intimal thickening. When two tangential sections of vessels 
were observed close by in the same biopsy piece, they were 
considered the same vessel, and two transversally cut sections 
of vessels, not close by, in the same biopsy piece were 
considered separate vessels. Areas close to healed biopsy sites 
were excluded for analysis of vessel morphology. Vascular 
changes were qualitatively recorded as present or absent, and 
specific features described previously were noted (8). 
Immunoperoxidase assessment of tumor necrosis factor- 
alpha, fibronectin and RHAMM in the endomyocardial biopsy 
specimens. Deparafl:inized sections were used for all immuno- 
peroxidase staining procedures, as previously described (5). 
Briefly, to determine whether there was a qualitative difference 
in the localization or amount of tumor necrosis factor-alpha a 
monoclonal antihuman immunoglobulin G [IgG] tumor necro- 
sis factor-alpha ntibody (1:200 dilution, ascites fluid, IgG 1 
from Sera-Lab [Crawley Down, Sussex, United Kingdom] was 
used. To assess the presence of fibronectin, amonoclonal IgG 1 
antihuman cellular fibronectin antibody was used (1:500 dilu- 
tion, ascites fluid, Upstate Biotechnology Inc.), and to assess 
the presence of cells expressing RHAMM, a polyclonal anti- 
body was used (1:1000 dilution) (a kind gift from Dr. Eva 
Turley, University of Manitoba) (9). 
After incubation with the various primary antibodies, the 
sections were rinsed in phosphate-buffered saline/bovine se- 
rum albumin solution at 0.07%, incubated with the appropriate 
secondary antibody for 45 rain and developed with 3,3'- 
diaminobenzidine (Sigma Corp.) for 5 to 10 rain for polyclonal 
or monoclonal ntibodies, respectively. Control sections were 
treated with phosphate-buffered saline or appropriate normal 
isotypic IgG (Dako Corporation), or both. 
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In all immunohistochemical analyses, the sections were 
viewed under a standard light microscope using 10×, 20× and 
40× objectives. The presence or absence of each antigen 
associated with small arteries in the sections was examined by 
two independent observers (N.C., S.M.) blinded to clinical 
history and ultrasound measurements. 
Intracoronary ultrasound studies. Selective coronary an- 
giography was carried out using the standard femoral approach 
and nonionic contrast dye. For intracoronary ultrasound im- 
aging, an 8F guide catheter was advanced into the left main 
coronary ostium and used for positioning of the guide wire and 
for passage of the imaging catheter. Before insertion of the 
imaging catheter, 10,000 U of heparin was administered intra- 
venously. Intracoronary ultrasound of the left descending 
anterior coronary artery was performed using the CV1S imag- 
ing system. The imaging catheter had a mechanically rotated 
30-MHz transducer mounted at the tip of a 4.3F catheter, 
which was advanced into the left descending anterior coronary 
artery over a 0.14 flexible, steerable angioplasty wire under 
fluoroscopic control. The imaging catheter was advanced as far 
into the vessel as was safely possible, and images were obtained 
from 8 to 10 segments while the catheter was withdrawn up to 
the left main coronary arteu. Images were recorded on S-VHS 
tape with simultaneous fluoroscopic ontrol for subsequent 
digitizing and analysis. At lcast eight vessel segments were 
recorded from each patient. 
The intracoronary ultrasound images wcrc digitizcd into a 
computer system (Freeland Imaging Medical Inc.) for quanti- 
tative analysis. All segments were analyzed by one observer 
(E.L.), who was unaware of clinical history., histologic features 
or acetylcholine r sponse of each patient. The lumcn-vcsscl 
wall interface was traced by planimetry, and, when visible, the 
external border of the intimal layer identified by the elastic 
lamina was also planimetered. An index of intimal thickness 
was calculated as Intimal area/(Lumen + Intimal area) for 
each segment. A mean intimal index was obtained for each 
patient by averaging all segments. 
Functional studies of left descending coronaD" artery. 
After an 8F guide catheter was positioned in the left main 
artery, and before the intracoronary ultrasound studies, serial 
2-min infusions of the endothelium-dependent vasodilator 
acetylcholine (Miochol, Iolab Pharmaceuticals) with estimated 
final concentrations of 10 " and 10 s tool/liter were per- 
formed. Then, 200/xg of the endothelium-independent vaso- 
dilator nitroglycerin was administcred intracoronarily. Coro- 
nary angiographic mages were obtained after each infusion. 
During each infusion, blood pressure, heart rate and electro- 
cardiogram were continuously monitored. 
Quantitative coronary analysis was performed using thc 
Cardiac Measurement System (Medical Imaging Systems, 
Neunen, Netherlands), aspreviously described (10). One prox- 
imal and one midsegment of the left anterior descending 
coronau artery were analyzed. The segments had to be from 
optimal areas for quantitative angiographic analysis: nonover- 
lapping images not on bifurcation areas and with good image 
quality. Segments of 1- to 3-cm lengths were digitized, and an 
average lumen diameter for each segment was derived. The 
same segments were digitized at baseline immediately after 
each acetylcholine infusion and following nitroglycerin i fu- 
sion. The vessel diameter after nitroglycerin fusion was used 
as a reference for calculating diameter changes after acetyl- 
choline infusion. Analysis was based on the highest dose of 
acetylcholine tolerated. The diameter change for each vessel 
was calculated on the basis of the average of the two segments. 
A diameter change of 0.6 mm less than that after nitroglycerin 
infusion was considered an abnormal vasoconstrictor response 
to acetylcholine and used for all analyses thereafter. 
Statistical analysis. Results are expressed as mean value _+ 
SD. Nonparametric analysis by chi-square (Fisher exact est) 
was used to assess the association between categoric variables. 
For comparisons using continuous variables of interest, a 
Student t test or linear regression was used when appropriate. 
Differences were considered significant at p -< 0.05. 
Resu l ts  
Clinical characteristics relative to histopathologic features. 
In 9 of 39 patients no small arteries (excluding capillaries) 
could be identified at biopsy; therefore, our study included 30 
patients. Fourteen of these 30 patients had abnormal small- 
artery histologic findings but were similar to 16 patients with 
normal small-artery histologic findings with respect o age 
(53 +_ 7 vs. 50 + 9 years, p = 0.4), donor age (32 +_ 10 vs. 27 _+ 
9 years, p = 0.1) and time after transplantation (24 _+ 20 vs. 
28 +_ 11 months, p = 0.9, range 2 to 60). 
Assessment of small intramyoeardial arteries. Histologic 
evidence of vascular changes. Of the 30 patients with small 
arteries present at biopsy, histologic evidence of allograft 
vasculopathy was observed in 14. The number of small arteries 
observed in each biopsy specimen ranged from one to three. 
Vascular changes observed included plump endothelial cells 
(n = 14) and concentric intimal thickening (n = 11). Intimal 
thickening was associated with accumulation of extracellular 
matrix material in the subendothelial space or with a layer of 
large "foamy" cells that appeared to be large macrophages or 
smooth muscle cells (Fig. 1). 
lmmunohistochemistry. ASSESSMENT OF FIBRONECTIN. Immu- 
noperoxidase assessment of fibronectin associated with small 
vessels in the biopsy specimens was possible for only 20 
patients. This was because the patients were retrospectively 
selected, and the biopsy sections were previously routinely 
processed without he use of specially coated slides that would 
prevent loss of tissue with pronase digestion, a necessary step 
in this particular staining procedure. Fibronectin immuno- 
staining was technically feasible in 20 patients, and the pres- 
ence of fibronectin in the vessel wall was observed in 14. The 
presence of fibronectin in small arteries was significantly 
associated with histopathologic evidence of small-artery dis- 
ease (p - 0.01). Fibronectin was detected in 9 of 9 patients 
with small (abnormal) arteries as judged by histologic findings 
and in only 5 of 11 with normal histologic findings. Fibronectin 
was associated with cells that were most likely smooth muscle 
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Figure 1. Representative photomicrographs. A, Normal small in- 
tramyocardial rtery observed in endomyocardial biopsy specimen. 
Inset shows a higher magnification of the normal-appearing endo- 
thelium. B, Abnormal small intramyocardial rtery found in an 
endomyocardial biopsy specimen. Marked intimal thickening is 
observed. C, Small intramyocardial rtery showing plump endothe- 
lial cells. The myocardium is unremarkable in A, B and C. A and 
B, elastic trichrome x40; C, elastic trichrome x 100; inset, oil x 100, 
all reduced by 10%. 
J O 
cells, as judged by phenotypic appearance, and was also 
present in the endothelial region and in the extracellular space 
(Fig. 2A and 3A). 
ASSESSMENT OF TUMOR NECROSIS FACTOR-ALPHA. Immuno- 
peroxidase assessment for the presence of tumor necrosis 
factor-alpha in the small arteries identified at endomyocardial 
biopsy was feasible in all 30 patients. The presence of tumor 
necrosis factor-alpha in the small arteries did not correlate 
with abnormal histologic findings (p - 0.71). Immunostaining 
for tumor necrosis factor-alpha was positive in 12 of 30 
patients, 6with and 6 without histologic evidence of vasculopa- 
thy. Tumor necrosis factor-alpha was evident in the vessel wall, 
both cell associated and in the extracellular space. Cells that 
stained positively for tumor necrosis factor-alpha ppeared to 
be inflammatory, endothelial or smooth muscle cells. There 
was a trend toward correlation of tumor necrosis factor-alpha 
and fibronectin (p = 0.1) because tumor necrosis factor-alpha 
was detected in 9 of 14 patients with fibronectin and in only 1 
of 6 patients without fibronectin (Fig. 2B and 3A and B). 
ASSESSMENT OF RHAMM. Immunoperoxidase taining for 
RHAMM in small arteries was carried out for all 30 patients. 
Positive staining for RHAMM was observed in 13 patients and 
was cell associated and apparent in the extracellular space. The 
cells that stained positively for this protein appeared to be 
smooth muscle cells, as judged by phenotypic appearance. The 
presence of RHAMM in these vessels did not correlate with 
abnormal histologic findings (p = 0.71), but a trend was 
observed between the expression of RHAMM and fibronectin 
(p = 0.1), and a significant association was observed between 
RHAMM and tumor necrosis factor-alpha expression (p = 
0.001) (Fig. 2C and 3A and C). 
Assessment of large epicardial coronary arteries. Intra- 
coronan, ultrasound assessment. All patients had some degree 
of intimal thickening, as judged by intracoronary ultrasound, 
with intimal indexes ranging between 0.004 to 0.36. There was 
no association between severity of disease by ultrasound and 
recipient or donor age (p = 0.4, r 2 - 0.02; p = 0.4, r 2 = 0.02, 
respectively). However, there was a strong association between 
the presence of disease by ultrasound and time since trans- 
plantation (p _< 0.0001, r 2 -- 0.49). Four patients with an 
intimal index >0.2 were considered to have severely abnormal 
intimal thickening. Most patients had both concentric and 
eccentric areas of intimal thickening, as assessed qualitatively 
by ultrasound (Fig. 4). 
Functional assessment of vascular endothelium. Quantita- 
tive analysis of the left anterior descending coronary diameter 
after acetylcholine infusion revealed 13 patients with abnormal 
vasoconstrictor response relative to dilation with nitroglycerin. 
We did not observe an association between morphologic 
changes, as assessed by intracoronary ultrasound measure- 
ments and endothelial dysfunction after acetylcholine infusion 
(p = 0.9). 
Correlation of markers of large- and small-vessel coronary 
artery disease. We failed to demonstrate a significant corre- 
lation between large-artery disease by ultrasound and small- 
114 CLAUSELL ET AL. JACC Vol. 26, No. 1 
VASCULOPATHY IN ( 'ARDIAC TRANSPLANT RECIPIENTS July 1995:110-9 
Figure 2. Representative photomicrographs. A, Fibronectin on a small 
intramyocardial artery with marked intimat hickening observed in an 
endomyocardial biopsy specimen. Intense staining is noted on the 
endothelium and subendothelium, although positive staining is also 
observed in the medial ayer. Inset, intense staining on the endothe- 
lium. B, Tumor necrosis factor-alpha on a small intramyocardial artery. 
Diffuse staining is observed in the vascular wall. C, lmmunoperoxidase 
staining for receptor for hyaluronan-mediated motility on small in- 
tramyocardial rtery. Positive staining is observed iffusely in the 
vessel wall but also associated with cells. A, immunoperoxidase ×60: B 
and C, immunoperoxidase × 100; inset, oil × 100, all reduced by 10%. 
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artery disease by histologic evidence, either by the Student 
test or by nonparametric analysis. Ultrasound intimal indexes 
from patients with normal and abnormal histologic findings 
were not statistically different (0.09 - 0.08 vs. 0.12 + 0.1, p = 
0.3, confidence interval [CI] -0.03 to 0.1) (Fig. 5A). Similarly, 
by nonparametric analysis, with thresholds for ultrasound 
intimal index of either 0.15 to represent severe disease or the 
median value of 0.08, there was no correlation between large- 
and small-artery disease (p = 0.7 and p = 0.5, respectively). In
fact, even among the four patients with a severely abnormal 
intimal index by ultrasound (>0.2), two had histologic evi- 
dence of small-artery disease, and two had normal small 
arteries. In addition, the response of large vessels to acetylcho- 
line infusion did not correlate with small-artery disease as- 
sessed by histologic study (normal vs. abnormal findings, 7 of 
16 vs. 6 of 14, p = 0.3 by the Fisher exact est, CI -0.18 to 0.17) 
(Fig. 5B). 
Moreover, when immunohistochemical analysis was used to 
assess small-artery disease, we still could not demonstrate a 
significant association between large- and small-artery disease, 
although intimal index values tended to be higher overall in the 
groups with positive immunostaining (Fig. 5A). Specifically, a
similar ultrasound-derived intimal index was seen in the pres- 
ence or absence of fibronectin (0.13 _+ 0.12 vs. 0.07 _+ 0.09, p = 
0.3, CI -0.056 to 0.172), and only a trend was observed with 
regard to the presence or absence of tumor necrosis factor- 
alpha (0.14 + 0.11 vs. 0.08 _+ 0.07, p = 0.09, CI -0.010 to 
0.124) and RHAMM (0.13 -+ 0.11 vs. 0.08 -+ 0.07, p = 0.1, 
CI -0.018 to 0.127). Nonparametric analysis also failed to 
demonstrate an association between large-artery disease and 
immunostaining for fibronectin (p = 0.4), and only a trend 
was observed for tumor necrosis factor-alpha (p = 0.06) and 
RHAMM (p = 0.1). A vasoconstrictor response to acetylcho- 
line in large vessels also showed no association with immuno- 
histochemical markers of small-artery disease (fibronectin, p = 
0.6: tumor necrosis factor-alpha, p = 0.2; RHAMM, p = 0.6) 
(Fig. 5B). 
Discuss ion  
In the present study we detected small intramyocardial 
arteries in the majority (76%) of surveillance ndomyocardial 
biopsy specimens and reported features of allograft vasculopa- 
thy in 40% by routine histologic study and 70% using fibronec- 
tin as a marker of disease. To our knowledge, this is the first 
report to both systematically investigate small-vessel disease 
and correlate the abnormalities with intracoronary ultrasound 
and analysis of endothelial function in large vessels. We could 
not identify a significant association between histologic or 
immunohistochemistry abnormalities of small vessels and 
structural or functional variables of large-vessel disease. These 
results suggest hat there may be discordance of a temporal 
and perhaps etiologic nature in the pathophysiology of al- 
lograft vasculopathy in large and small vessels. 
Methodologic onsiderations. Our findings should be in- 
terpreted in the light of certain methodologic considerations. 
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Figure 3. Bar graphs illustrating small- 
artery histologic and immunohisto- 
chemical findings. A, Percent of pa- 
tients with positive immunostaining 
for fibronectin (FN), tumor necro- 
sis factor-alpha (TNF-a) and recep- 
tor for hyaluronan-mediated motility 
(RHAMM) relative to the number of 
patients with abnormal small-artery 
histologic findings. Only the presence 
of fibronectin correlated with abnor- 
mal histologic findings because all 
patients who had positive staining 
for fibronectin in the vessels had ab- 
normal histologic findings. The pres- 
ence of tumor necrosis factor-alpha or 
RHAMM did not predict small-artery 
disease. B, Percent of patients with 
positive staining for fibronectin rela- 
tive to the presence of tumor necrosis 
factor-alpha or RHAMM in small in- 
tramyocardial arteries. The presence 
of fibronectin did not correlate with 
the presence of tumor necrosis factor- 
alpha or RHAMM on small arteries. 
C, Strong correlation between pres- 
ence of tumor necrosis factor-alpha 
and presence of RHAMM because all 
the patients with positive immuno- 
staining for RHAMM also had posi- 
tive staining for tumor necrosis factor- 
alpha. 
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Patients were entered in the study from our cardiac transplant 
recipient population at the time of their routine annual 
coronary angiographic assessment. They represent a usual 
cardiac transplant recipient group in terms of time since 
transplantation (range 2 to 60 months) and only four patients 
were studied within the first 6 months after transplantation. 
However, this group was selected for the absence of flow- 
limiting epicardial vessel disease, the absence of cellular 
rejection requiring treatment and for survival to the time of the 
study. Patients in the present study were further subselected 
for the presence of intramyocardial arteries in their biopsy 
samples, which we presumed to be a random process. Because 
small arteries were observed in a high proportion of patients 
(76%), it is unlikely that we would have underestimated the 
prevalence of disease or its severity. Although the small 
arteries in each specimen were similar morphologically, only a 
few arteries were available for analysis, and only 30 patients 
were assessed. Thus, we cannot exclude sampling bias in our 
results, and a correlation might have been achieved had a 
larger number of vessels or patients been analyzed. Ultrasound 
and endothelial function studies were limited to the left 
anterior descending coronary artery, which might also reflect a 
sampling bias. Because both the functional and structural 
studies reflect one time point in a progressive disease, longi- 
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Figure 4. Representative intracoronary 
ultrasound image from a cardiac trans- 
plant recipient illustrating concentric n- 
timal thickening in the left anterior de- 
scending coronary artery. Diagrammatic 
planimetry of the cross section of the 
vessel is illustrated on the right. EL = 
elastic lamina; L -- vessel lumen. 
tudinal studies will be of value in determining whether there is 
consistent dissociation in pathobiology. 
Small-artery disease. In the present series, abnormal his- 
tologic features of small intramyocardial rteries on endomyo- 
cardial biopsy were observed in 40% of cases. The findings 
include plump endothelial cells and intimal thickening that 
appeared to result from accumulation of extracellular matrix 
material or intimal cells or both. Immunologic characterization 
of the cellular components in the intima was not possible 
because of the scarce availability of sections and the difficulty 
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Figure 5. Graphs depicting the relation between intimal 
index and endothelial dysfunction with immunohistochem- 
ical markers. A, Scatter graph illustrating the relation 
between intimal index measured by intracoronary ultra- 
sound in the left anterior descending artery and markers of 
small-artery disease by histologic (Hist.) and immunohis- 
tochemical nalysis. Values for intimal index were higher 
overall when abnormal histologic findings were detected or 
when positive immunostaining for fibronectin (FN), tumor 
necrosis factor-alpha (TNF-a) and receptor for hyaluronan- 
mediated motility (RHAMM) was observed, but no signifi- 
cant association was found, although trends were observed for 
tumor necrosis factor-alpha and RHAMM. B, Bar graph 
illustrating the relation between endothelial dysfunction mea- 
sured by vessel diameter after acetylcholine infusion and 
markers of small-artery disease by histologic and immunohis- 
tochemical nalysis. No correlation was observed between the 
presence of endothelial dysfunction and any indication of 
small-artery disease, including histologic findings, and pres- 
ence of fibronectin, tumor necrosis factor-alpha and 
RHAMM. 
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in obtaining immune reagents compatible with paraffin- 
embedded sections. Although we are relatively confident, as 
are others (8), in judging the intimal cells as macrophages and 
smooth muscle cells, the presence of other cell types, such as 
lymphocytes, cannot be excluded. In keeping with autopsy 
series reported from cardiac allografts (8,11,12) and also 
described in one case involving both biopsy and autopsy 
specimens (4), the intimal thickening in small intramyocardial 
arteries observed here appeared to be almost always concen- 
tric. However, in autopsy series the prevalence of intramyocar- 
dial coronary artery disease was much higher. This may 
represent larger sampling of myocardial tissue or a much more 
advanced stage of disease because the patients either died of a 
cardiac-related event or had retransplantation because of 
allograft vasculopathy (8,12). In the present study, functional 
status of the graft was not correlated with biopsy samples 
because they were analyzed and compared with intravascular 
ultrasound studies at one point in time. 
Small.artery immunohistochemical analysis. Light micro- 
scopic analysis of the endomyocardial biopsy sections was 
extended by immunohistochemical analysis to identify early 
features of allograft vasculopathy described in our previous 
animal studies. Experimental llograft vasculopathy is associ- 
ated with an immune-inflammatory reaction in the vessel wall, 
expression of cytokines (interleukin-l-beta and tumor necrosis 
factor-alpha) and accumulation of fibronectin (5). In the 
present study, fibronectin was observed in 70% of patients and 
correlated with histologic changes of allograft vasculopathy. 
All vessels with abnormal histologic findings had positive 
staining for fibronectin. However, 5 of 11 of the patients with 
normal histologic findings also had positive fibronectin stain- 
ing. Because we previously demonstrated (5) that fibronectin 
accumulation i piglets preceded light microscopic evidence of 
intimal thickening in allograft coronary arteries, this finding 
may indicate some degree of underlying disease ven in these 
"normal" vessels. 
Accumulation of subendothelial fibronectin is also observed 
with atherosclerosis (13). Because fibronectin can form a 
gradient promoting cell movement (14), its presence in the 
vessel wall could be related to increased smooth muscle cell 
migration into the subendothelium, as we described in ductus 
arteriosus (7). In addition, fibronectin can promote transendo- 
thelial migration of lymphocytes by the interaction of its 
connecting segment-1 and arginine-glycine-aspartatc binding 
sites to different integrins (alpha-4 beta-I and alpha-5 beta-l) 
on the surface of inflammatory cells (15,16). 
The inflammatory mediator tumor necrosis factor-alpha 
was expressed in intramyocardial rteries in 40% of patients. 
No patient had active cellular rejection requiring treatment. 
However, the presence of tumor necrosis factor-alpha was not 
consistently associated with morphologically abnormal small 
arteries. It could be speculated, therefore, that in the dynamic 
process of immune activation of the endothelium, vascular 
cells are induced to produce cytokines before the development 
of neointimal thickening. We previously showed (17,18) in 
experimental lograft vasculopathy that neointimal thickening 
was associated with a reciprocal co-induction of tumor necrosis 
factor-alpha and interleukin-l-beta, which modulate fibronec- 
tin synthesis by endothelial and smooth muscle cells. More- 
over, we demonstrated (19) that in vivo neutralization f tumor 
necrosis factor-alpha in rabbits after cardiac transplantation 
inhibited the development of neointimal thickening. 
Others have shown that expression of tumor necrosis 
factor-alpha in vessels may have several functions, including 
activation of endothelial cells (20), expression of adhesion 
molecules (21) and proliferation of smooth muscle cells (22). 
To our knowledge, the present study is the first to document 
the presence of tumor necrosis factor-alpha inhuman allograft 
microvasculature in vivo and, on the basis of our previous 
experimental studies, supports the important role of tumor 
necrosis factor-alpha in the pathogenesis of allograft vascu- 
lopathy. Although other cytokines might also be involved (23), 
we restricted our study to tumor necrosis factor-alpha on the 
basis of our previous experimental studies howing adirect role 
of tumor necrosis factor-alpha in the development of vascular 
lesions (19). 
In the present study, RHAMM was observed in only 43% of 
patients but correlated with the expression of tumor necrosis 
factor-alpha in the small arteries. It is possible that tumor 
necrosis factor-alpha regulates expression of RHAMM, as has 
been described for transforming growth factor-beta (9). Be- 
cause there was a trend toward an association between the 
expression of RHAMM as well as tumor necrosis factor-alpha 
with fibronectin in the small intramyocardial arteries, it is 
possible that RHAMM is also an early feature that precedes 
the accumulation of fibronectin and abnormal vascular histo- 
logic findings. In our previous studies (7), increased uctus 
arteriosus mooth muscle cell migration i  vitro was associated 
with increased production of fibronectin and RHAMM (7). 
Others (24) have shown that accumulation f RHAMM occurs 
at the tips of lamellipodia of advancing cells and that poly- 
clonal anti-RHAMM can block cell motility. 
Comparison of large, and small-artery disease. In the 
present study, the large epicardial vessels were assessed with 
intracoronary ultrasound, which has been shown to be a 
sensitive measurement of intimal thickening (3,25). Although 
our study was limited to assessing about he first two-thirds of 
the left anterior descending coronary artery, it is likely to be 
representative of the disease in the large epicardial vessels. As 
reported by others (25), some degree of intimal thickening was 
identifable in all patients, and some patients howed marked 
intimal thickening. However, our results did not support a 
similar extent of disease in large epicardial vessels and small 
intramyocardial rteries, although we cannot exclude this 
possibility should a large cohort of patients be assessed in 
future studies. Nonetheless, comparing the intimal index gen- 
erated by ultrasound measurements as a continuous variable 
versus small-artery histologic findings, there was no evidence 
of association, although some higher values were observed in 
the group of patients with abnormal histologic findings. But, 
even among the four patients with the worst disease in the 
epicardial vessels, only two had small-artery disease, and two 
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had normal-appearing small arteries. Even with the increased 
sensitiviW of fibronectin, there was still no convincing evidencc 
of an association. 
In the present study, an abnormal vasoconstrictor response 
to acetylcholine identified endothelial dysfunction (26,27) in 
43% of the study group, a prevalence similar to that reported 
by others (28) in cardiac transplant recipients. There was no 
correlation between the vasoconstrictor response to acetylcho- 
line and morphologic disease as detected by intracorona U 
ultrasound inthe same vessel segments, and this has also been 
previously reported in other series (29). There was also no 
association between large-vessel ndothelial dysfunction and 
morphologic disease in small arteries as assessed by histologic 
study or even by fibronectin immunostaining or expression of 
tumor necrosis factor-alpha orRHAMM. This further suggests 
that the pathogenesis of large- and small-artery disease may be 
discordant. By contrast, he lack of correlation may result from 
temporally related factors in which small vessel disease would 
serve as a "predictor" of large-vessel disease, with the immu- 
nologic insult traveling proximally. Alternatively, the presence 
of large-vessel disease in the absence of small-vessel disease 
may imply healing of an initial injury. 
Differences in pathobiology and rate of progression of 
disease in the large and small arteries may account for the 
heterogeneous clinical presentation of allograft vasculopathy 
after cardiac transplantation. Part of this discordance may 
arise from the superimposition of a conventional theroscle- 
rotic process active in large vessels or the preexistence of 
minimal or mild coronary, arteu disease (8,12), or both, which 
may spare, at least in part, the microvasculature. Microvascular 
endothelium differs from that of the large-vessel ndothelium 
with respect o antigenic omposition, metabolic properties, 
response to growth factors, structure and function (30,31). 
Summary. We demonstrated that myocardial biopsy spec- 
imens from cardiac transplant recipients can be used to detect 
allograft vasculopathy in small arteries. In keeping with our 
previous experimental work 15), the expression of fibronectin 
and tumor necrosis factor-alpha in small arteries in biopsy 
specimens indicates apathophysiologic process contributing to 
intimal thickening. However, this process was not reflected by 
simultaneous disease in large epicardial vessels, as assessed by 
either ultrasound or acetylcholine challenge. Longitudinal 
studies involving serial intravascular ultrasound and functional 
assessment of the cardiac graft will be necessary to determine 
whether these differences become manifest through differences 
in clinical presentation a d outcome. 
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